{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:57:43Z","timestamp":1774443463558,"version":"3.50.1"},"reference-count":43,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Background: Congenital cytomegalovirus (cCMV) infection is one of the most common congenital infections worldwide and the leading cause of non-genetic sensorineural hearing loss. Although less frequent in preterm infants, cCMV may significantly worsen outcomes in an already vulnerable population. The risks and benefits of antiviral therapy in extremely preterm neonates remain unclear, as this group is largely excluded from clinical trials. Case presentation: We report a case of symptomatic cCMV infection in an extremely preterm infant born at 26 weeks and 2 days of gestation to a mother with primary CMV infection during the second trimester. High CMV viral loads were detected in urine and plasma shortly after birth. On day of life (DOL) 3, respiratory deterioration required intubation, with radiological findings consistent with CMV pneumonia and positive bronchoaspirate samples. Intravenous ganciclovir was initiated on DOL 16 and administered for six weeks, followed by oral valganciclovir for six months. Treatment was associated with a favourable clinical and virological response and no significant hematological toxicity. Ophthalmologic and audiological evaluations were normal. Neurodevelopmental assessment with Bayley III at one year of corrected age demonstrated age-appropriate performance across all domains. Discussion: A structured literature review identified 10 case reports, including 13 extremely preterm infants treated for cCMV infection. Antiviral dosing regimens were heterogeneous. The most frequent manifestations prompting treatment were laboratory abnormalities (92.3%), particularly thrombocytopenia and leukopenia or neutropenia. Neuroimaging abnormalities and intrauterine growth restriction or small for gestational age were each reported in 53.8% of cases. Long-term neurodevelopmental outcomes were normal in 38.5% of infants. Conclusions: Antiviral therapy for cCMV infection with ganciclovir and valgancyclovir in premature neonates is feasible and safe with careful monitoring, and appears to provide benefits. Nevertheless, well-designed studies that include pharmacokinetics and pharmacodynamics, virologic monitoring, and long term outcomes of development, vision and hearing are urgently needed.<\/jats:p>","DOI":"10.3390\/v18030391","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:02:43Z","timestamp":1774026163000},"page":"391","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antiviral Treatment for Congenital Cytomegalovirus Infection in Extremely Preterm Newborn: A Case Report and Literature Review"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2481-0692","authenticated-orcid":false,"given":"Giovanni","family":"Boscarino","sequence":"first","affiliation":[{"name":"Pediatric Clinic, Pietro Barilla Children\u2019s Hospital, University Hospital of Parma, 43126 Parma, Italy"},{"name":"Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giusy","family":"Davino","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Pietro Barilla Children\u2019s Hospital, University Hospital of Parma, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Pezzoni","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Pietro Barilla Children\u2019s Hospital, University Hospital of Parma, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Corradi","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Pietro Barilla Children\u2019s Hospital, University Hospital of Parma, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6777-1721","authenticated-orcid":false,"given":"Maria","family":"Pera","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Pietro Barilla Children\u2019s Hospital, University Hospital of Parma, 43126 Parma, Italy"},{"name":"Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4103-2837","authenticated-orcid":false,"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Pietro Barilla Children\u2019s Hospital, University Hospital of Parma, 43126 Parma, Italy"},{"name":"Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enzo","family":"Romanini","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Pietro Barilla Children\u2019s Hospital, University Hospital of Parma, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Chiopris, G., Veronese, P., Cusenza, F., Procaccianti, M., Perrone, S., Dacc\u00f2, V., Colombo, C., and Esposito, S. (2020). Congenital Cytomegalovirus Infection: Update on Diagnosis and Treatment. Microorganisms, 8.","DOI":"10.3390\/microorganisms8101516"},{"key":"ref_2","unstructured":"Ziebold, C., and Pillarisetty, L.S. (2025). Congenital Cytomegalovirus Infection, StatPearls Publishing."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/INF.0000000000004960","article-title":"Prognostic Factors of Late-onset Hearing Loss in Infants With Congenital Cytomegalovirus and Normal Audiologic Assessment at Birth","volume":"45","author":"Buonsenso","year":"2026","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Boscarino, G., Romano, R., Tegoni, F., Iotti, C., Perrone, S., Esposito, S., and Buonsenso, D. (2024). Congenital Cytomegalovirus Severity Definitions and Treatment Decisions around the World: A Systematic Scoping Review of the Literature. J. Clin. Med., 13.","DOI":"10.3390\/jcm13195997"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Moutsopoulou, R.A., Markou, A., Lianou, A., Leontari, K., Iliodromiti, Z., Boutsikou, T., Kafalidis, G., Paliatsiou, S., Volaki, P., and Iacovidou, N. (2025). Congenital Cytomegalovirus Infection: From Silent Threat to Vaccine Horizon. Vaccines, 13.","DOI":"10.3390\/vaccines13090929"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Valente Dias, J., Mar\u00e7al, M., and Tuna, M. (2025). Breast Milk-acquired Cytomegalovirus Infection in Premature or Very Low Birth Weight Infants: A Systematic Review. Pediatr. Infect. Dis. J., ahead of printing.","DOI":"10.1097\/INF.0000000000005120"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00006454-200102000-00014","article-title":"Congenital cytomegalovirus infection in preterm and full-term newborn infants from a population with a high seroprevalence rate","volume":"20","author":"Yamamoto","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1542\/peds.2013-2217","article-title":"Incidence and impact of CMV infection in very low birth weight infants","volume":"133","author":"Turner","year":"2014","journal-title":"Pediatrics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/s41390-025-04232-5","article-title":"Beyond hearing loss: Exploring neurological and neurodevelopmental sequelae in asymptomatic congenital cytomegalovirus infection","volume":"98","author":"Swanson","year":"2025","journal-title":"Pediatr. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s40746-022-00261-y","article-title":"Perinatal Cytomegalovirus Infection","volume":"8","author":"Carmona","year":"2022","journal-title":"Curr. Treat. Options Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100892","DOI":"10.1016\/j.lanepe.2024.100892","article-title":"Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)","volume":"40","author":"Chatzakis","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3390\/clinpract14060191","article-title":"Progress and Challenges in the Management of Congenital Cytomegalovirus Infection","volume":"14","author":"Szulc","year":"2024","journal-title":"Clin. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e70093","DOI":"10.1002\/rmv.70093","article-title":"Advancements and Uncertainties in the Treatment of Congenital CMV Disease","volume":"36","author":"Vipulanandan","year":"2026","journal-title":"Rev. Med. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Melville, J.M., and Moss, T.J.M. (2013). The immune consequences of preterm birth. Front. Neurosci., 7.","DOI":"10.3389\/fnins.2013.00079"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kimberlin, D.W., Banerjee, R., Barnett, E.D., Lynfield, R., and Sawyer, M.H. (2024). Cytomegalovirus infections. Red Book: 2024 Report of the Committee on Infectious Diseases, American Academy of Pediatrics. [33rd ed.].","DOI":"10.1542\/9781610027373"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Acosta, E.P., Aban, I., Ryan, K.J., S\u00e1nchez, P.J., Rodriguez, C.A., Romero, J.R., Sood, S.K., Abughali, N., Arav-Boger, R., and DeBiasi, R.L. (2025). Ganciclovir Dosing in Premature Infants Receiving Treatment for Congenital Cytomegalovirus Infection: Results of a Prospective Pharmacokinetic Study. J. Infect. Dis., jiaf528.","DOI":"10.1093\/infdis\/jiaf528"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1164\/rccm.201812-2348OC","article-title":"The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach","volume":"200","author":"Jensen","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/sj.jp.7211357","article-title":"Nonimmune hydrops fetalis and fulminant fatal disease due to congenital cytomegalovirus infection in a premature infant","volume":"25","author":"Sampath","year":"2005","journal-title":"J. Perinatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/sj.jp.7211854","article-title":"Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant","volume":"28","author":"Brandhorst","year":"2008","journal-title":"J. Perinatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00431-009-0941-0","article-title":"Congenital cytomegalovirus infection associated with severe lung involvement in a preterm neonate: A causal relationship?","volume":"168","author":"Koklu","year":"2009","journal-title":"Eur. J. Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0030-1263130","article-title":"Neurodevelopmental outcome following congenital cytomegalovirus infection in preterm infants with twin-to-twin transfusion syndrome: A case report","volume":"222","author":"Griesmaier","year":"2010","journal-title":"Klin. Padiatr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1080\/14767058.2017.1312331","article-title":"Persistent intestinal bleeding due to severe CMV-related thrombocytopenia in a preterm newborn","volume":"31","author":"Berardi","year":"2018","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Morimoto, M., Sawada, H., Yodoya, N., Ohashi, H., Toriyabe, K., Hanaki, R., Sugiura, K., Toyoda, H., Matsushita, K., and Koike, Y. (2020). Refractory Ileal Perforations in a Cytomegalovirus-Infected Premature Neonate Resolved After Ganciclovir Therapy. Front. Pediatr., 8.","DOI":"10.3389\/fped.2020.00352"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/ped.14636","article-title":"Valganciclovir therapy for a neonate with congenital cytomegalovirus pneumonitis","volume":"63","author":"Kanda","year":"2021","journal-title":"Pediatr. Int."},{"key":"ref_25","first-page":"93","article-title":"Treatment of Congenital Cytomegalovirus and Ganciclovir Therapeutic Drug Monitoring in Twin Preterm Infants","volume":"28","author":"Chiasson","year":"2023","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e15755","DOI":"10.1111\/ped.15755","article-title":"Successful valganciclovir treatment initiated beyond 60 days of age in a preterm infant with congenital cytomegalovirus disease","volume":"66","author":"Okahashi","year":"2024","journal-title":"Pediatr. Int."},{"key":"ref_27","first-page":"e61576","article-title":"Lissencephaly and Advanced-Stage Congenital Cytomegalovirus Infection in a Neonate","volume":"16","author":"Manalac","year":"2024","journal-title":"Cureus"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Anderson, J., Bender, G., Minh Thang, C., Quang Thanh, L., Thi Trang Dai, V., Van Thanh, P., Thi Hong Nhu, B., Ngoc Xuan Trang, D., Thi Phuong Trinh, P., and Vu Thuong, N. (2023). TLR Responses in Preterm and Term Infant Cord Blood Mononuclear Cells. Pathogens, 12.","DOI":"10.3390\/pathogens12040596"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/infdis\/jiv071","article-title":"Functional Exhaustion Limits CD4+ and CD8+ T-Cell Responses to Congenital Cytomegalovirus Infection","volume":"212","author":"Huygens","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Anderson, J., Thang, C.M., Thanh, L.Q., Dai, V.T.T., Phan, V.T., Nhu, B.T.H., Trang, D.N.X., Trinh, P.T.P., Nguyen, T.V., and Toan, N.T. (2021). Immune Profiling of Cord Blood From Preterm and Term Infants Reveals Distinct Differences in Pro-Inflammatory Responses. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.777927"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"105756","DOI":"10.1016\/j.jcv.2024.105756","article-title":"Houston Congenital Cytomegalovirus Longitudinal Study Group. Cytomegalovirus urinary excretion in children with congenital and postnatally acquired infection","volume":"176","author":"Lanzieri","year":"2025","journal-title":"J. Clin. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.jcv.2009.08.012","article-title":"Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system","volume":"46","author":"Oliver","year":"2009","journal-title":"J. Clin. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Turriziani Colonna, A., Buonsenso, D., Pata, D., Salerno, G., Chieffo, D.P.R., Romeo, D.M., Faccia, V., Conti, G., Molle, F., and Baldascino, A. (2020). Long-Term Clinical, Audiological, Visual, Neurocognitive and Behavioral Outcome in Children With Symptomatic and Asymptomatic Congenital Cytomegalovirus Infection Treated With Valganciclovir. Front. Med., 7.","DOI":"10.3389\/fmed.2020.00268"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1474-4422(08)70294-1","article-title":"Brain injury in premature infants: A complex amalgam of destructive and developmental disturbances","volume":"8","author":"Volpe","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Arcieri, F., Vasta, A., Sorrenti, S., Volpe, G., D\u2019Ambrosio, V., Di Mascio, D., Natale, F., Manganaro, L., Liuzzi, G., and Corigliano, M.C. (2026). Antenatal Imaging and Neonatal Outcome in Infants with Congenital Cytomegalovirus Infection: The Effect of Valaciclovir. J. Clin. Med., 15.","DOI":"10.3390\/jcm15020809"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","article-title":"Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: A randomized, controlled trial","volume":"143","author":"Kimberlin","year":"2003","journal-title":"J. Pediatr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1404599","article-title":"Valganciclovir for symptomatic congenital cytomegalovirus disease","volume":"372","author":"Kimberlin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/INF.0000000000001763","article-title":"Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management","volume":"36","author":"Luck","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbmt.2007.03.009","article-title":"Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis","volume":"13","author":"Battiwalla","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"S490","DOI":"10.1093\/clinids\/10.Supplement_3.S490","article-title":"Antiviral activity and mechanism of action of ganciclovir","volume":"10","author":"Matthews","year":"1988","journal-title":"Rev. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/INF.0000000000004605","article-title":"Dosing, Toxicity and Drug Concentrations for Ganciclovir\/Valganciclovir in Preterm and Low Birthweight Infants Treated for Cytomegalovirus","volume":"44","author":"Payne","year":"2025","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/uog.26136","article-title":"Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: Systematic review and meta-analysis","volume":"61","author":"Marinceu","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1093\/jac\/dkae247","article-title":"In utero treatment of congenital cytomegalovirus infection with valganciclovir: An observational study on safety and effectiveness","volume":"79","author":"Bourgon","year":"2024","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/3\/391\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:14:59Z","timestamp":1774433699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/3\/391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["v18030391"],"URL":"https:\/\/doi.org\/10.3390\/v18030391","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}